Investigational Site Number : 2030003

Brno 65691

1 studies enrolling now · 5 studies all time

What they study most

Crohn's Disease, Heart Failure, Multiple Sclerosis, Neoplasm Malignant, Psoriasis, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. — Recruiting now
• First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL — Completed
• A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis — Completed
• Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis — Running, not enrolling
• Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) — Stopped early